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Experimental Details  
Antioxidant Activities  
2,2-Diphenyl-1-picrylhydrazyl (DPPH) assay: The DPPH assay was conducted according to method by 
Fu et al. with minor modification [1]. 100 µL of DPPH stock solution (0.1 mM) was mixed with sample 
100 µL and incubated for 30 minutes in the dark at room temperature. The absorbance was measured 
using EPOCH microplate reader at 517 nm. The sample was replaced with methanol for blank sample. 
Percentage inhibition was calculated using the following formula: 
Percentage inhibition = [(Absorbance blank DPPHAbsorbance sample)/ Absorbance blank DPPH] × 
100% 
2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) assay: The ABTS assay was carried out 
based on method described by Zou et al. with minor modification [2]. ABTS and potassium persulfate 
were dissolved in distilled water to obtain concentration 7 mM and 4.9 mM respectively. Equal amount of 
these two solutions were mixed and let stand for 12 to 16 hours at room temperature before use. The 
ABTS radical was added with distilled water to absorbance of 0.7 at 734 nm. 10 µL of sample was added 
to 96-well plates together with 190 µL of ABTS solutions. The absorbance was recorded after 30 minutes 
incubation in the dark at room temperature. The percentage of antioxidant activity was calculated using 
the following formula: 
Scavenging concentration = [Abs (ABTS)Abs (ABTS+Sample)/Abs (ABTS)] × 100% 
Ferric reducing antioxidant potential (FRAP) assay: Experiment was carried out according to 
Channarong et al. with minor modification [3]. FRAP reagent was freshly prepared, consist of stock 
solution with ratio 10:1:1 of 300 mM acetate buffer, 10 mM TPTZ in 40 mM HCl and 20 mM 
FeCl3.6H2O solution. 5 µL of sample, 15 µL of methanol and 150 µL of FRAP reagent were added to the 
96-well plates. The absorbance at 573 nm was read after 10 minutes of incubation at 37°C. FeSO4.7H2O 




Statistical Analysis of Data:  
Three replicates of each sample were used for statistical analysis with values reported as mean ± SD. 
Standard curves were generated and calculation of the 50% inhibitory concentration (IC50) values was 
performed using GraphPad Prism for Windows (Version 5.02) software. The test was carried out using 
SPSS (version 16) software to study the comparison between treatment of samples and untreated control. 
A value of p < 0.05 was considered significantly different. 
 
4',5-Dihydroxy-6,7-(2,2-dimethylpyrano)-2'-methoxy-8-γ,γ-dimethylallylflavone (1) : Pale yellow solid 
(66.7 mg, 1.67%). Rf 0.38 (n-Hex:EtOAc = 1:1);  IR (ATR) υ max cm
-1
: 3393 (OH), 2943 (sp
3 
CH), 1649 
(C=O), 1622  and 1561 (C=C aromatic), and 1208 (C-O); 
1
H NMR (CD3COCD3, 400 MHz) ppm: δ 13.68 
(1H, s, 5-OH), 7.73 (1H, d, J = 8.4 Hz, H-6'), 6.76 (1H, s, H-3), 6.73 (1H, dd, , J = 16.4 Hz and 7.2 Hz, 
H-10), 6.65 (1H, dd, J = 8.4 Hz and 2.4 Hz, H-5'), 6.60 (1H, d, J = 16.4 Hz, H-9), 6.45 (1H, d, J = 2.4 Hz, 
H-3'), 6.24 (1H, d, J = 9.2 Hz, H-14), 5.48 (1H, d, J = 9.2 Hz, H-15), 4.00 (3H, s, OCH3), 2.45 ( 1H, m, 
H-11), 1.96 (3H, s, H-17), 1.70 (3H, s, H-18), 1.09 ( 6H, s, H-12 and H-13); 
13
C NMR (CD3COCD3, 100 
MHz) ppm: δ 178.5 (C-4), 163.2 (C-4'), 162.7 (C-2'), 158.9 (C-8a), 155.7 (C-2), 155.3 (C-5), 141.7 (C-
10), 138.0 (C-16), 125.4 (C-6'), 121.2 (C-15), 115.8 (C-9), 109.9 (C-5'), 109.5 (C-6), 109.2 (C-8), 107.5 
(C-1'), 105.1 (C-4a), 104.0 (C-3'), 90.2 (C-3), 69.5 (C-14), 55.8 (O-CH3), 33.1 (C-11), 24.9 (C-18), 22.2 





























































































































































































































































































































H NMR spectrum of 4',5-dihydroxy-6,7-(2,2-dimethylpyrano)-2'-methoxy-8-γ,γ-






















































































































































































H NMR spectrum of 4',5-dihydroxy-6,7-(2,2-dimethylpyrano)-2'-methoxy-8-γ,γ-



























































































































































































Cudraflavone A (2) : Yellow needles (5.4 mg, 0.03%). Rf  0.45 (n-hexane: EtOAc = 4 :1), );  IR (ATR) υ 
max cm
-1
: 3403 (OH), 2976 (sp
3 
CH), 1649 (C=O), 1622  and 1561 (C=C aromatic), and 1208 (C-O); 
 1
H 
NMR (CD3COCD3, 400 MHz) δ ppm: 13.29 (s, 5-OH), 7.74 (1H, d, J = 8.4 Hz, H-5'), 6.68 (1H, d, J = 
10.0 Hz, H-14), 6.64 (1H, dd, J = 8.4 Hz and 2.4 Hz, H-4'), 6.48 (1H, s, H-8), 6.44 (1H, d, J = 2.4 Hz, H-
2'), 6.21  (1H, d, J = 9.2 Hz , H-10), 5.79 (1H, d, J = 10.0 Hz, H-15), 5.49 (1H, d, J = 9.2 Hz, H-9), 1.96 
(3H, s, H-17), 1.70 (3H, s, H-18), 1.46 (6H, s, H-12 and H-13) ; 
13
C-NMR (CD3COCD3, 100 MHz) δ 
ppm: 178.3 (C-4), 163.4 (C-7), 159.0 (C-5), 158.2 (C-2), 156.4 (C-8a), 156.3 (C-3'), 155.8 (C-6'), 137.9 
(C-11), 128.5 (C-15), 125.4 (C-5'), 121.2 (C-9), 114.9 (C-14), 110.1 (C-6'), 109.1 (C-4'), 107.4 (C-3), 
105.2 (C-6), 105.2 (C-4a), 104.0 (C-2'), 94.9 (C-8), 77.8 (C-16), 69.4 (C-10), 27.4 (C-12 and C-13),  24.9 
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Artocarpin (3): Orange powder (41.2 mg, 0.23%); Rf  0.43 (n-hexane: EtOAc = 3:2), IR (ATR) υ max cm
-1
:  
3365 (OH), 2958 (sp
3 
CH), 1646 (C=O), 1615  and 1466 (C=C aromatic) and 1203 (C-O); 
1
H-NMR 
(CD3COCD3, 400 MHz) δ ppm: 13.98 (1H, s, 5-OH), 8.84 (2H, s, 2'-OH/4'-OH), 7.24 (1H, d, J = 8.4 Hz,  
H-6'), 6.74 (1H, dd, J = 16.4 Hz and 7.2 Hz, H-15), 6.62 (2H, d, J = 16.4 Hz, H-14), 6.58 (1H, d, J = 2.4 
Hz, H-3'), 6.57 (1H, s, H-8), 6.54 (1H, dd, J = 8.4 Hz and 2.4 Hz, H-5'), 5.13 (1H, t, J = 7.2 Hz, H-10),  
3.98 (3H, s, 7-OCH3 ), 3.14 (1H, d, J = 7.2 Hz, H-9), 2.45 (1H, m, H-16), 1.59 (3H, s, H-13), 1.45  (3H, s, 
H-12), 1.10 (6H, d, J = 6.4 Hz, H-17 and H-18); 
13
C-NMR (CD3COCD3, 100 MHz) δ ppm: 182.4 (C-4), 
162.9 (C-7), 161.6 (C-2), 160.6 (C-5), 158.9 (C-4'), 156.6 (C-8a), 156.3 (C-2'), 141.3 (C-15), 131.4 (C-
6'), 121.1 (C-10), 121.0 (C-3), 116.1 (C-14), 112.0 (C-1'), 108.9 (C-6), 107.2 (C-5'), 104.7 (C-4a), 102.9 
(C-3'), 89.7 (C-8), 55.7 (7-OCH3), 33.1 (C-16), 24.9 (C-12), 23.7 (C-9), 22.2 (C-17 and C-18), 16.7 (C-
























































H NMR spectrum of artocarpin (3) 
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Cycloartobiloxanthone (4): Orange powder (7 mg, 0.04%) : Rf  0.5 (n-hexane: EtOAc = 3:2), IR (ATR) υ 
max cm
-1
:  3404 (OH), 2975 (sp
3 
CH), 1622 (C=O); 
 1
H-NMR (CD3COCD3, 400 MHz) δ ppm: 13.41 (s, 5-
OH), 6.95 (1H, d, J = 10.0 Hz, H-14), 6.43 (1H, s, H-3'), 6.16 (1H, s, H-6), 5.70 (1H, d, J = 10.0 Hz, H-
15), 3.44 (1H, dd, J =15.2 and 6.8 Hz, H-9b), 3.23 (1H, dd, J = 15.2 and 6.8 Hz,  H-10), 2.40 (1H, t, J = 
15.2 Hz, H-9a), 1.68 (3H, s, H-13), 1.48 (6H, s, H-17/18), 1.34 (3H, s, H-12); 
13
C-NMR (CD3COCD3, 
100 MHz) δ ppm: 180.5 (C-4), 161.7 (C-7), 160.6 (C-2), 158.6 (C-5), 151.2 (C-8a), 150.6 (C-2'), 146.2 
(C-4'), 137.0 (C-5'), 132.8 (C-6'), 126.9 (C-15), 115.0 (C-14), 111.8 (C-3), 104.5 (C-1'), 103.9 (C-4a), 
100.9 (C-8), 99.0 (C-7), 92.8 (C-11), 77.8 (C-16), 46.6 (C-10), 31.3 (C-12), 27.5 (C-17 and C-18), 22.4 
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CH), 1649 (C=O), 1622  and 1561 (C=C aromatic), and 1208 (C-O), (CD3COCD3, 400 
MHz) δ ppm: 13.26 (s, 5-OH), 6.89 (1H, s, H-6'), 6.63 (1H, d, J = 10.0 Hz, H-14), 6.61 (1H, s, H-3'), 6.17 
(1H, s, H-6), 5.69 (1H, d, J = 10.0 Hz, H-15), 5.14 (1H, t, J = 7.2 Hz, H-10), 3.15 (2H, d,  J = 7.2 Hz H-
9), 1.59 (3H, s, H-13), 1.48 (3H, s, H-12), 1.46 (6H, s,  H-17 and 18); 
13
C-NMR (CD3COCD3, 100 MHz) 
δ ppm: 182.4 (C-4), 161.8 (C-5), 161.1 (C-2), 159.0 (C-7), 152.3 (C-8a), 148.8 (C-4'), 138.1 (C-5'), 131.4 
(C-11), 127.1 (C-15), 121.5 (C-10), 120.7 (C-3), 116.1 (C-6ʹ), 114.5 (C-14), 110.5 (C-1'), 104.7 (C-4a), 
103.7 (C-3'), 100.7 (C-8), 98.7 (C-6), 77.8 (C-16), 27.3 (C-17 and C-18), 24.9 (C-12), 23.7 (C-9), 16.7 






























































































































































































































































H NMR spectrum of artonin E (5) 
 
















































































































































































Oxyresveratrol (6) Yellow solid; (24.6 mg, 0.45%). Rf 0.38 (n-hexane:Et2O = 2:3);  IR (ATR) υ max cm
-1
: 
3209 (OH), 2921 (sp
3 
CH), 1589 (C=C aromatic); 
1
H NMR (CD3COCD3, 400 MHz)  δ ppm : 7.43 (1H, d, 
J = 8.4 Hz, H-6), 7.35 (1H, d, J =16.4 Hz, H-β), 6.91 (1H, d, J = 16.4 Hz, H-α ), 6.53 (1H, d, J = 2.0 Hz, 
H-2' and H- 6'), 6.45 (1H, d, J = 2.4 Hz, H-3), 6.39 (1H, dd, J = 8.4, 2.4 Hz,  H-5), 6.24 (1H, t, J = 2.0 Hz, 
H-4'); 
13
C-NMR (CD3COCD3, 100 MHz) δ ppm : 158.7 (C-3',5'), 158.2 (C-2), 156.0 (C-4), 140.8 (C-1'), 
127.4 (C-6), 125.5 (C-α), 123.5 (C-β), 116.4 (C1), 107.6 (C-5), 104.6 (C-2' and C-6'), 102.7 (C-3), 101.4 






























































































































































































































































































Macakurzin C (7): Yellow needle (3.3 mg, 0.07%); Rf 0.38 (n-hexane:EtOAc = 1:1);  IR (ATR) υ max cm
-
1
: 3319 (OH), 2917 and 2847 (sp
3 
CH), 1652 (C=O) and 1584 (C=C aromatic); 
1
H NMR (CDCl3, 400 
MHz) δ ppm: 12.21 (1H, s, 5-OH), 8.43  (1H, s, 3-OH), 8.32 (2H, d, J = 6.8 Hz, H-2' and H-6'), 7.56 (2H, 
t, J = 6.8 Hz, H-3' and H-5'), 7.55 (1H, d, J = 7.5 Hz, H-4'), 6.96 (1H, d, J = 10.0 Hz, H-9), 6.23 (1H, s, 
H-8), 5.80 (1H, d, J = 10.0 Hz, H-10), 1.50 (6H, s, H-12 and H-13); 
13
C NMR (CDCl3, 100 MHz) δ ppm: 
175.6 (C-4), 160.5 (C-7), 160.0 (C-9), 151.2 (C5), 144.8 (C-2), 136.6 (C-3), 130.9 (C-1'), 130.3 (C-4′), 
128.9 (C-8'), 128.7 (C-3' and C-5'), 127.5 (C-2' and C-6'), 114.7 (C-7'), 103.8 (C-6), 101.44 (C-10), 99.8 




















































































S33: EIMS spectrum of macakurzin C (7)  
Flemichapparin A (8): red solid (17.5 mg, 0.44 %); Rf  0.5 (n-hexane:EtOAc = 4:1); IR (ATR) υ max cm
-1
: 
3242 (OH), 2917 (sp
3 
CH), 1594,  1465 (C=C aromatic); 
 1
H-NMR (CD3COCD3, 400 MHz) δ ppm : 14.13 
(1H, s, 5-OH), 8.13 (1H, d, J = 16.0 Hz, H-β), 7.79 (1H, d, J=16.0 Hz, H-α), 7.41-7.64 (5H, m, H-2'-H-
6'), δ 6.61 (1H, d, J=10.0 Hz, H-1"), 6.00 (1H, s, H-6), 5.52 (1H, d, J=10.0 Hz, H-2"), 1.58 (6H, s,  H-
4"/5"); 
13
C NMR (CD3COCD3, 100 MHz) δ ppm: 192.9 (C-1), 166.6 (C-3), 158.3 (C-7), 156.7 (C-5), 
142.3 (C-α), 135.6 (C-1'), 130.9 (C-1'), 128.4 (C-3',C-4'  and C-5'), 127.5 (C-2' and C-6'), 127.5 (C-β),  
124.8 (C-2"), 106.6 (C-1"), 102.4 (C-4), 96.4 (C-6), 78.2 (C-3"), 28.1 (C-5"), 28.0 (C-4"); EIMS m/z (% 






























































































Luteolin (9): yellow solid (13 mg, 0.13%) ; Rf 0.55 (n-hexane:EtOAc = 2:3);  IR (ATR) υ max cm
-1
: 3421 
(OH), 2957, 2925 and 2632 (sp
3 
CH), 1653 (C=O), 1608 (C=C aromatic);  
1
H NMR (CD3COCD3, 400 
MHz)  δ ppm: 13.05 (1H, s, 5-OH), 7.15 (1H, d, J = 2.4 Hz, H-2'), 7.49 (1H, dd, J = 8.4 Hz and 2.4 Hz, 
H-6'), 7.01 (1H, d, J = 8.4 Hz, H-5'), 6.60 (1H, s, H-3), 6.54 (1H, d, J = 2.0 Hz, H-6), 6.26 (1H, d, J = 2.0 
Hz,  H-8); 
13
C-NMR (CD3COCD3, 100 MHz) δ ppm: 182.1 (C-4), 164.3 (C-2), 164.1 (C-5), 162.5 (C-7), 
157.9 (C-8a), 149.5 (C-3'), 145.7 (C-4'), 122.7 (C-1'), 119.2 (C-6'), 115.8 (C-5'), 113.2 (C-2'), 104.4 (C-


























































C spectrum of luteolin (9)  
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Apigenin (10): yellow solid (5 mg, 0.05%); Rf 0.45 (n-hexane:EtOAc = 1:1);  IR (ATR) υ max cm
-1
: 3426 
(OH), 2962, 2920 and 2628 (sp
3 
CH), 1658 (C=O), 1608 (C=C aromatic);   
1
H NMR (CD3COCD3, 400 
MHz)  δ ppm : 13.04 (1H, s, 5-OH),  7.96 (2H, d, J = 8.4 Hz, H-2' and H-6'), 7.04 (2H, d, J =8.4 Hz, H-3' 
and H-5'), 6.65 (1H, s, H-3 ), 6.56 (1H, d, J = 2.0 Hz, H-6), 6.27 (1H, d, J = 2.0 Hz, H-8); 
13
C-NMR 
(CD3COCD3, 100 MHz) δ ppm : 182.2 (C-4), 164.2 (C-5), 164.0 (C-2), 162.5 (C-4'), 161.0 (C-9), 157.9 
(C-7), 128.4 (C-2'/6'), 122.4 (C-1'), 115.9 (C-3'/5'), 104.5 (C-10), 103.2 (C-3), 98.8 (C-6), 93.8 (C-8);  
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